Published in Bioorg Med Chem Lett on July 01, 2010
The importance of IL-1 beta and TNF-alpha, and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis. J Immunol (2002) 1.76
Expression of chemokine receptor CXCR3 on T cells affects the balance between effector and memory CD8 T-cell generation. Proc Natl Acad Sci U S A (2011) 1.28
Essential role of Fc gamma receptors in anti-type II collagen antibody-induced arthritis. J Immunol (2003) 1.22
Essential role of neutrophils in anti-type II collagen antibody and lipopolysaccharide-induced arthritis. Immunology (2006) 1.21
Intravital analysis of vascular permeability in mice using two-photon microscopy. Sci Rep (2013) 1.11
In vivo imaging of T-cell motility in the elicitation phase of contact hypersensitivity using two-photon microscopy. J Invest Dermatol (2011) 0.97
Prostaglandin E2 increase in pachydermoperiostosis without 15-hydroprostaglandin dehydrogenase mutations. Acta Derm Venereol (2013) 0.89
PGD2 induces eotaxin-3 via PPARγ from sebocytes: a possible pathogenesis of eosinophilic pustular folliculitis. J Allergy Clin Immunol (2011) 0.89
Tetrahydropyridine derivatives with inhibitory activity on the production of proinflammatory cytokines: part 1. Bioorg Med Chem Lett (2009) 0.81
R-130823, a novel inhibitor of p38 MAPK, ameliorates hyperalgesia and swelling in arthritis models. Eur J Pharmacol (2004) 0.81
Novel p38 MAP kinase inhibitor R-130823 suppresses IL-6, IL-8 and MMP-13 production in spheroid culture of human synovial sarcoma cell line SW 982. Immunol Lett (2005) 0.79
Novel p38 mitogen-activated protein kinase inhibitor R-130823 protects cartilage by down-regulating matrix metalloproteinase-1,-13 and prostaglandin E2 production in human chondrocytes. Int Immunopharmacol (2005) 0.79
Anti-type II collagen antibody accelerates arthritis via CXCR2-expressing cells in IL-1 receptor antagonist-deficient mice. Eur J Immunol (2007) 0.79
Histamine modulates the responsiveness of keratinocytes to IL-17 and TNF-α through the H1-receptor. J Dermatol Sci (2010) 0.79
High-mobility group box 1 protein (HMGB1) as a novel diagnostic tool for toxic epidermal necrolysis and Stevens-Johnson syndrome. Arch Dermatol (2011) 0.77
Discovery of CS-2100, a potent, orally active and S1P3-sparing S1P1 agonist. Bioorg Med Chem Lett (2012) 0.77
Synthesis and SAR of 1,3-thiazolyl thiophene and pyridine derivatives as potent, orally active and S1P₃-sparing S1P₁ agonists. Bioorg Med Chem Lett (2012) 0.77
Use of an exposure-response model to aid early drug development of an oral sphingosine 1-phosphate receptor modulator. J Clin Pharmacol (2008) 0.77
Tetrahydropyridine derivatives with inhibitory activity on the production of proinflammatory cytokines: part 2. Bioorg Med Chem Lett (2010) 0.75
Oral allergy syndrome complicated with multiple food sensitization detected by specific IgEs. Eur J Dermatol (2012) 0.75
Synthesis and evaluation of CS-2100, a potent, orally active and S1P(3)- sparing S1P(1) agonist. Eur J Med Chem (2012) 0.75
Forty-two-day-old boy with acute idiopathic thrombocytopenic purpura. Pediatr Int (2010) 0.75
Neonatal goiter with congenital thyroid dysfunction in two infants diagnosed by MRI. Pediatr Radiol (2004) 0.75
PCR-RFLP analysis for S2889X in filaggrin harbors the risk of a typing error. J Dermatol Sci (2012) 0.75
Syntheses of glucose analogues of E5564 as a highly potent anti-sepsis drug candidate. Bioorg Med Chem (2006) 0.75
Skin tape stripping and cheek swab method for a detection of filaggrin. J Dermatol Sci (2013) 0.75
Syntheses of glucose derivatives of E5564-related compounds and their LPS-antagonistic activities. Carbohydr Res (2006) 0.75